Evaluation of Early Bactericidal Activity and Safety in Pulmonary Tuberculosis With WX-081

Condition:   Pulmonary Tuberculosis Interventions:   Drug: WX-081;   Drug: Bedaquiline;   Drug: Standard treatment;   Drug: Multi-drug background treatment (MBT) Sponsor:   Shanghai Jiatan Pharmatech Co., Ltd Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials